Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

Follow-up of three years of treatment with growth hormone and of one post-treatment year, in children with severe growth retardation of intrauterine onset.

Job JC, Chaussain JL, Job B, Ducret JP, Maes M, Olivier M, Ponte C, Rochiccioli P, Vanderschueren-Lodeweyckx M, Chatelain P.

Pediatr Res. 1996 Feb;39(2):354-9.

PMID:
8825812
2.

Hormonal treatment of cryptorchidism: lessons from 15 years of worldwide experience.

Bourguignon JP, Vanderschueren-Lodeweyckx M.

Acta Urol Belg. 1995 May;63(2):77-81. Review. No abstract available.

PMID:
7785546
3.

Dose-dependent catch-up growth after 2 years of growth hormone treatment in intrauterine growth-retarded children. Belgian and French Pediatric Clinics and Sanofi-Choay (France).

Chatelain P, Job JC, Blanchard J, Ducret JP, Oliver M, Sagnard L, Vanderschueren-Lodeweyckx M.

J Clin Endocrinol Metab. 1994 Jun;78(6):1454-60.

PMID:
8200949
4.
5.

Comparison between the human serum growth hormone-binding protein and the water-soluble growth hormone-binding site released from IM-9 lymphocytes.

Massa G, Ilondo M, Vanderschueren-Lodeweyckx M.

Acta Endocrinol (Copenh). 1993 Dec;129(6):559-64.

PMID:
8109191
6.

Effect of oestrogen status on serum levels of growth hormone-binding protein and insulin-like growth factor-I in non-pregnant and pregnant women.

Massa G, Igout A, Rombauts L, Frankenne F, Vanderschueren-Lodeweyckx M.

Clin Endocrinol (Oxf). 1993 Nov;39(5):569-75.

PMID:
8252747
7.

Non-endemic Burkitt's lymphoma in a patient with Bloom's syndrome.

Vandenberghe E, Van Hove J, Brock P, Schmidt P, Delabie J, Casteels-Van Daele M, Cassiman JJ, Vanderschueren-Lodeweyckx M, Van den Berghe H.

Leuk Lymphoma. 1993 Jul;10(4-5):377-82.

PMID:
8220137
8.

Normalization of decreased plasma concentrations of growth hormone-binding protein by insulin treatment in spontaneously diabetic BB rats.

Massa G, Verhaeghe J, Vanderschueren-Lodeweyckx M, Bouillon R.

Horm Metab Res. 1993 Jun;25(6):325-6. No abstract available.

PMID:
8344651
9.

Opposite effects of growth hormone and estrogens on the pregnancy zone protein serum levels in children and adolescents.

Devriendt K, Massa G, de Zegher F, Vanderschueren-Lodeweyckx M, Cassiman JJ, Van den Berghe H, Marynen P.

Acta Endocrinol (Copenh). 1993 Apr;128(4):334-8.

PMID:
8498151
10.

[Growth and hormones: from fetus to adult].

Vanderschueren-Lodeweyckx M.

Rev Med Suisse Romande. 1993 Mar;113(3):219-23. French. No abstract available.

PMID:
8480117
11.
12.

Influence of spontaneous or induced puberty on the growth promoting effect of treatment with growth hormone in girls with Turner's syndrome.

Massa G, Maes M, Heinrichs C, Vandeweghe M, Craen M, Vanderschueren-Lodeweyckx M.

Clin Endocrinol (Oxf). 1993 Mar;38(3):253-60.

PMID:
8458097
13.

Growth of children in a iodine-deficient area in northern Zaïre.

Van den Broeck J, Eeckels R, Van Loon H, Van Miert M, Vanderschueren-Lodeweyckx M.

Ann Hum Biol. 1993 Mar-Apr;20(2):183-9.

PMID:
8447661
14.

Five-year follow-up of growth hormone antibodies in growth hormone deficient children treated with recombinant human growth hormone.

Massa G, Vanderschueren-Lodeweyckx M, Bouillon R.

Clin Endocrinol (Oxf). 1993 Feb;38(2):137-42.

PMID:
8435894
15.

Intelligence, behaviour and psychosocial development in Turner syndrome. A cross-sectional study of 50 pre-adolescent and adolescent girls (4-20 years).

Swillen A, Fryns JP, Kleczkowska A, Massa G, Vanderschueren-Lodeweyckx M, Van den Berghe H.

Genet Couns. 1993;4(1):7-18.

PMID:
8471226
16.

The effect of simple obesity on growth and growth hormone.

Vanderschueren-Lodeweyckx M.

Horm Res. 1993;40(1-3):23-30. Review.

PMID:
8300046
17.

Deletion of the short arm of the X chromosome: a hereditary form of Turner syndrome.

Massa G, Vanderschueren-Lodeweyckx M, Fryns JP.

Eur J Pediatr. 1992 Dec;151(12):893-4.

PMID:
1473542
18.
19.

Delayed spontaneous pubertal growth spurt in girls with Ullrich-Turner syndrome.

Massa G, Vanderschueren-Lodeweyckx M.

Am J Med Genet. 1992 Sep 1;44(1):124-5. No abstract available.

PMID:
1489413
20.

Serum levels of growth hormone-binding protein and insulin-like growth factor-I during puberty.

Massa G, Bouillon R, Vanderschueren-Lodeweyckx M.

Clin Endocrinol (Oxf). 1992 Aug;37(2):175-80.

PMID:
1395068
21.

Serum growth hormone-binding proteins in the human fetus and infant.

Massa G, de Zegher F, Vanderschueren-Lodeweyckx M.

Pediatr Res. 1992 Jul;32(1):69-72.

PMID:
1635847
22.

Hyperthyroidism accelerates growth in Turner's syndrome.

Massa G, de Zegher F, Dooms L, Vanderschueren-Lodeweyckx M.

Acta Paediatr. 1992 Apr;81(4):362-4.

PMID:
1606402
23.

Cellular processing of growth hormone in IM-9 cells: evidence for exocytosis of internalized hormone.

Ilondo MM, Vanderschueren-Lodeweyckx M, Courtoy PJ, De Meyts P.

Endocrinology. 1992 Apr;130(4):2037-44.

PMID:
1547727
24.

Thyroid dyshormonogenesis: severe hypothyroidism after normal neonatal thyroid stimulating hormone screening.

de Zegher F, Vanderschueren-Lodeweyckx M, Heinrichs C, Van Vliet G, Malvaux P.

Acta Paediatr. 1992 Mar;81(3):274-6.

PMID:
1511207
25.

Serum levels of immunoreactive inhibin, FSH, and LH in human infants at preterm and term birth.

Massa G, de Zegher F, Vanderschueren-Lodeweyckx M.

Biol Neonate. 1992;61(3):150-5.

PMID:
1610942
26.

Age and height at diagnosis in Turner syndrome: influence of parental height.

Massa GG, Vanderschueren-Lodeweyckx M.

Pediatrics. 1991 Dec;88(6):1148-52.

PMID:
1956730
27.

Growth hormone (GH) treatment in short normal children: absence of influence of time of injection and resistance to GH autofeedback.

Chanoine JP, Vanderschueren-Lodeweyckx M, Maes M, Thiry-Counson G, Craen M, Van Vliet G.

J Clin Endocrinol Metab. 1991 Dec;73(6):1269-75.

PMID:
1955508
28.

Malignant disease in Bloom's syndrome children treated with growth hormone.

Brock PR, de Zegher F, Casteels-Van Daele M, Vanderschueren-Lodeweyckx M.

Lancet. 1991 Jun 1;337(8753):1345-6. No abstract available.

PMID:
1674317
29.

Growth hormone treatment of Turner syndrome patients with insufficient growth hormone response to pharmacological stimulation tests.

Massa G, Vanderschueren-Lodeweyckx M, Craen M, Vandeweghe M, van Vliet G.

Eur J Pediatr. 1991 May;150(7):460-3.

PMID:
1915494
30.

Effect of growth hormone therapy on thyroid status of girls with Turner's syndrome.

Massa G, de Zegher F, Vanderschueren-Lodeweyckx M.

Clin Endocrinol (Oxf). 1991 Mar;34(3):205-9.

PMID:
2036729
31.

Growth hormone deficiency in a girl with the Cohen syndrome.

Massa G, Dooms L, Vanderschueren-Lodeweyckx M.

J Med Genet. 1991 Jan;28(1):48-50.

32.

Measuring growth hormone activity through receptor and binding protein assays.

Ilondo MM, Vanderschueren-Lodeweyckx M, De Meyts P.

Horm Res. 1991;36 Suppl 1:21-6. Review.

PMID:
1806479
33.

Perinatal growth hormone (GH) physiology: effect of GH-releasing factor on maternal and fetal secretion of pituitary and placental GH.

de Zegher F, Vanderschueren-Lodeweyckx M, Spitz B, Faijerson Y, Blomberg F, Beckers A, Hennen G, Frankenne F.

J Clin Endocrinol Metab. 1990 Aug;71(2):520-2.

PMID:
2143200
34.

Alobar holoprosencephaly, diabetes insipidus and coloboma without craniofacial abnormalities: a case report.

Van Gool S, de Zegher F, de Vries LS, Vanderschueren-Lodeweyckx M, Devlieger H, Casaer P, Eggermont E.

Eur J Pediatr. 1990 Jun;149(9):621-2.

PMID:
2373111
35.

Serum growth hormone levels measured by radioimmunoassay and radioreceptor assay: a useful diagnostic tool in children with growth disorders?

Ilondo MM, Vanderschueren-Lodeweyckx M, De Meyts P, Eggermont E.

J Clin Endocrinol Metab. 1990 May;70(5):1445-51.

PMID:
2186059
36.

Exercise therapy and hypocaloric diet in the treatment of obese children and adolescents.

Reybrouck T, Vinckx J, Van den Berghe G, Vanderschueren-Lodeweyckx M.

Acta Paediatr Scand. 1990 Jan;79(1):84-9.

PMID:
2316366
37.

Linear growth in patients with Turner syndrome: influence of spontaneous puberty and parental height.

Massa G, Vanderschueren-Lodeweyckx M, Malvaux P.

Eur J Pediatr. 1990 Jan;149(4):246-50.

PMID:
2303072
38.

Growth-promoting effect of growth hormone and low dose ethinyl estradiol in girls with Turner's syndrome.

Vanderschueren-Lodeweyckx M, Massa G, Maes M, Craen M, van Vliet G, Heinrichs C, Malvaux P.

J Clin Endocrinol Metab. 1990 Jan;70(1):122-6.

PMID:
2294126
39.

Hypersomatotropism in the dysmature infant at term and preterm birth.

de Zegher F, Kimpen J, Raus J, Vanderschueren-Lodeweyckx M.

Biol Neonate. 1990;58(4):188-91.

PMID:
2271715
40.

Recombinant human growth hormone treatment in short children with chronic renal disease, before transplantation or with functioning renal transplants: an interim report on five European studies.

Johansson G, Sietnieks A, Janssens F, Proesmans W, Vanderschueren-Lodeweyckx M, Holmberg C, Sipilä I, Broyer M, Rappaport R, Albertsson-Wikland K, et al.

Acta Paediatr Scand Suppl. 1990;370:36-42; discussion 43.

PMID:
2260456
41.

Who is treated with growth hormone today? The Executive Scientific Committee of the Kabi International Growth Study.

Vanderschueren-Lodeweyckx M.

Acta Paediatr Scand Suppl. 1990;370:107-13; discussion 114.

PMID:
2260448
42.

Assessment of growth hormone secretion: what are we looking for practically?

Vanderschueren-Lodeweyckx M.

Horm Res. 1990;33 Suppl 4:1-6. Review.

PMID:
2245964
43.

Treatment with human growth hormone: who, how, when and why?

Vanderschueren-Lodeweyckx M.

Acta Paediatr Scand Suppl. 1990;367:23-8. Review. No abstract available.

PMID:
2220384
44.

Spondyloepiphyseal dysplasia tarda in Turner syndrome.

Massa G, Vanderschueren-Lodeweyckx M.

Acta Paediatr Scand. 1989 Nov;78(6):971-4.

PMID:
2603728
45.

Hypothalamo-pituitary dysfunction in congenital toxoplasmosis.

Massa G, Vanderschueren-Lodeweyckx M, Van Vliet G, Craen M, de Zegher F, Eggermont E.

Eur J Pediatr. 1989 Aug;148(8):742-4.

PMID:
2792124
46.

Congenital hypothyroidism and monoamniotic twins.

de Zegher F, Vanderschueren-Lodeweyckx M.

Lancet. 1989 Jul 15;2(8655):169-70. No abstract available.

PMID:
2567946
47.

Congenital hypothyroidism and growth hormone deficiency.

De Zegher F, Vanderschueren-Lodeweyckx M, Suarez P, Dooms L, Kimpen J, Malvaux P.

Lancet. 1988 Dec 24-31;2(8626-8627):1489-90. No abstract available.

PMID:
2904599
48.

Bloom's syndrome. Clinical features and immunologic abnormalities of four patients.

Van Kerckhove CW, Ceuppens JL, Vanderschueren-Lodeweyckx M, Eggermont E, Vertessen S, Stevens EA.

Am J Dis Child. 1988 Oct;142(10):1089-93.

PMID:
3263039
49.

[Who needs growth hormones?].

Vanderschueren-Lodeweyckx M.

Tijdschr Kindergeneeskd. 1988 May;56 Suppl 1:42-3. Dutch. No abstract available.

PMID:
3413774
50.

Prediction of final height in boys with non-tumorous hypopituitarism.

Van den Broeck J, Vanderschueren-Lodeweyckx M, Eggermont E.

Eur J Pediatr. 1988 Apr;147(3):245-7.

PMID:
3391220

Supplemental Content

Loading ...
Support Center